SkyePharma PLC Company Profile (NASDAQ:SKYEY)

About SkyePharma PLC

SkyePharma PLC logoSkyepharma PLC (Skyepharma) is a specialty pharmaceutical company. The Company is engaged in the development and delivery of oral and inhalation pharmaceutical products. The Company's products pipeline includes four inhalation products, 10 oral products, one topical product and one injectable product. The Company's products include flutiform, Exparel, Paxil CR, Sular, Diclofenacratiopharm, Madopar DR and Coruno, among others. The Company's product flutiform is a multi-dose pressurized metered dose inhaler, utilizing SkyeDry technology, containing steroid (fluticasone) and a beta agonist (formoterol). flutiform is indicated for the treatment of asthma. Exparel is a bupivacaine injectable product indicated for post-surgical pain management. The Product utilizes Pacira Pharmaceuticals' DepoFoam technology. The Company has approximately 10 approved oral products that are sold in over 80 countries.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SKYEY
  • CUSIP:
Key Metrics:
  • Previous Close: $6.28
  • 50 Day Moving Average: $6.62
  • 200 Day Moving Average: $6.01
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for SkyePharma PLC (NASDAQ:SKYEY) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for SkyePharma PLC (NASDAQ:SKYEY)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for SkyePharma PLC (NASDAQ:SKYEY)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for SkyePharma PLC (NASDAQ:SKYEY)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for SkyePharma PLC (NASDAQ:SKYEY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for SkyePharma PLC (NASDAQ:SKYEY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for SkyePharma PLC (NASDAQ:SKYEY)
DateHeadline
capitalcube.com logoSkyePharma Plc : Neutral assessment on price but strong on fundamentals (NASDAQ:SKYEY)
www.capitalcube.com - June 2 at 4:18 PM
capitalcube.com logoSkyePharma Plc :SKYEY-US: Earnings Analysis: For the six months ended December 31, 2015 (NASDAQ:SKYEY)
www.capitalcube.com - March 21 at 2:35 PM
capitalcube.com logoSkyePharma Plc :SKYEY-US: Earnings Analysis: 2015 By the Numbers (NASDAQ:SKYEY)
www.capitalcube.com - March 21 at 11:59 AM
finance.yahoo.com logoMundipharma Appointed as Development and Marketing Partner for flutiform(R) in Mexico, Central and South America (NASDAQ:SKYEY)
finance.yahoo.com - January 28 at 2:25 AM
capitalcube.com logoSkyePharma Plc : Overvalued relative to peers, but may deserve another look (NASDAQ:SKYEY)
www.capitalcube.com - January 7 at 4:09 PM
capitalcube.com logoSkyePharma Plc – Value Analysis (US OTC:SKYEY) : October 28, 2015 (NASDAQ:SKYEY)
www.capitalcube.com - October 28 at 1:55 PM

Social

SkyePharma PLC (NASDAQ:SKYEY) Chart for Thursday, August, 25, 2016


Last Updated on 8/25/2016 by MarketBeat.com Staff